GT Biopharma (GTBP) Other Non-Current Assets (2009 - 2026)
GT Biopharma (GTBP) reported Other Assets of $507,000 for Q2 2026, down 36.6% from $800,000 a year earlier and down 11.1% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma posted Other Assets of $634,000, down 99.3% from FY2024.
- Other Assets has a three-year compound annual growth rate of 313.0% (FY2022 to FY2025).
- By year, Other Assets came in at $93 million in FY2024 and $9,000 in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Other Assets since Q3 2023.
- Year over year, Other Assets has now declined in each of the last four quarters, with an average decline of 83.6% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $570,000 (Q1 2026), $634,000 (Q4 2025) and $800,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 10.02 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 507,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 507,000.00 |
| Mar 31, 2026 | 570,000.00 |
| Dec 31, 2025 | 634,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 93.00 Mn |
| Dec 31, 2024 | 93.00 Mn |
| Sep 30, 2024 | 93.00 Mn |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Sep 30, 2020 | 84,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Sep 30, 2019 | 12,000.00 |
API Access
GT Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();